SCHEMBL30878142

SCHEMBL30878142

CC(C)(C)OC(=O)N[C@@H](COc1cnc2ccccc2c1C(=O)OCc1ccccc1)Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.47
▸ SYK P43405 1/20 0.45
▸ CYP3A4 P08684 3/20 0.42
▸ CTRB1 P17538 2/20 0.41
▸ CTSS P25774 3/20 0.41
▸ CTSL P07711 1/20 0.41
▸ CTSB P07858 1/20 0.41
▸ CTSK P43235 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ APP P05067 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30639541 0.90 ATM (0.51) ATMCYP3A4CTSSCTSLCTSB
SCHEMBL27032968 0.90 ATM (0.51) ATMCYP3A4CTSSCTSLCTSB
SCHEMBL27137035 0.90 ATM (0.51) ATMCYP3A4CTSSCTSLCTSB
SCHEMBL29828736 0.89 CTSS (0.49) ATMSYKCYP3A4CTSSCTSL
SCHEMBL30790785 0.87 ATM (0.43) ATMSYKCYP3A4CTRB1MAPT
SCHEMBL30639500 0.82 ATM (0.43) ATMSYKCYP3A4CTRB1MAPT
SCHEMBL29097022 0.82 ATM (0.43) ATMSYKCYP3A4CTRB1MAPT
SCHEMBL29096900 0.82 ATM (0.43) ATMSYKCYP3A4CTRB1MAPT
SCHEMBL29096903 0.82 ATM (0.43) ATMSYKCYP3A4CTRB1MAPT
SCHEMBL29828719 0.82 ATM (0.43) ATMSYKCYP3A4CTRB1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587012-A1 COMBINATION OF MACROCYCLIC CFTR MODULATORS WITH CFTR CORRECTORS AND / OR CFTR POTENTIATORS Idorsia Pharmaceuticals Ltd (CH) 2025-07-23 — — EP disclosed
WO-2024056791-A1 COMBINATION OF MACROCYCLIC CFTR MODULATORS WITH CFTR CORRECTORS AND / OR CFTR POTENTIATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-03-21 — — WO disclosed
Send feedback